Complete Surgical Resection Improves Outcomes for Localized Primary Angiosarcoma of Bone

Share this content:

the Cancer Therapy Advisor take:

According to a new study published in the American Journal of Clinical Oncology, complete surgical resection of primary angiosarcoma of bone is associated with better outcomes.

For the retrospective study, researchers sought to analyze treatments with activity and survival of patients with primary angiosarcoma of bone. They identified 60 patients with a median age of 54 year who were treated between 1980 and 2009.

Lesions were commonly found in the femur and pelvis, and 40% of patients had metastatic disease at the time of diagnosis. Nearly 72% of patients underwent surgery and about 70% of those patients achieved surgical complete remission. About 28% of patients received radiotherapy, 13 of those with localized disease received chemotherapy, and 15 of those with metastatic disease received chemotherapy.

Results showed that the 5-year overall survival was 20%. Specifically, the 5-year overall survival was 33% for those with localized disease and 0% for those with metastatic disease. Patients without metastatic disease had improved overall after achieving surgical complete remission and adjuvant chemotherapy with cisplatin, doxorubicin, and ifosfamide.

Of the 15 patients who received chemotherapy for metastatic disease, two RECIST partial responses were observed out of 13 evaluable patients, 1 of whom received paclitaxel and the other who received doxorubicin. Two patients had stable disease.

Bone Cancer
Complete surgical resection of primary angiosarcoma of bone is associated with better outcomes.
The authors performed a 2 institutional retrospective study to analyze treatment and survival of patients with angiosarcoma of bone. Complete surgical resection is essential for outcome.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs